First- vs second-generation antipsychotic drugs in schizophrenia

被引：2

作者：

Andrade, Chittaranjan ^{[1
]}

Kharawala, Saifuddin ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, La Canada Flintridge, CA 91011 USA

来源：

ARCHIVES OF GENERAL PSYCHIATRY | 2007年 / 64卷 / 08期

关键词：

D O I：

10.1001/archpsyc.64.8.978-b

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：978 / 979

页数：2

共 3 条

[1] Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) [J].

Jones, Peter B. ;

Barnes, Thomas R. E. ;

Davies, Linda ;

Dunn, Graham ;

Lloyd, Helen ;

Hayhurst, Karen P. ;

Murray, Robin M. ;

Markwick, Alison ;

Lewis, Shon W. .

ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (10) :1079-U6

[2] Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia - A randomized controlled trial [J].

Rosenheck, R ;

Perlick, D ;

Bingham, S ;

Liu-Mares, W ;

Collins, J ;

Warren, S ;

Leslie, D ;

Allan, E ;

Campbell, EC ;

Caroff, S ;

Corwin, J ;

Davis, L ;

Douyon, R ;

Dunn, L ;

Evans, D ;

Frecska, E ;

Grabowski, J ;

Graeber, D ;

Herz, L ;

Kwon, K ;

Lawson, W ;

Mena, F ;

Sheikh, J ;

Smelson, D ;

Smith-Gamble, V .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20) :2693-2702

[3]

Stahl SM, 2000, ESSENTIAL PSYCHOPHAR

← 1 →